Scott B. Brown - 12 Mar 2024 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role: CHIEF FINANCIAL OFFICER
Signature: /s/ Scott B. Brown
Issuer symbol: N/A
Transactions as of: 12 Mar 2024
Net transactions value: +$482
Form type: 4
Filing time: 13 Mar 2024, 17:59:38 UTC
Previous filing: 03 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TCON	Common Stock	Award	$482	+3,500	+16%	$0.1377	25,128	20 Apr 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCON	Employee Stock Option (Right to Buy)	Award	$0	+224,800		$0.000000	224,800	12 Mar 2024	Common Stock	224,800	$0.3900	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2023.
F2	1/4th of the shares subject to this option shall vest on the first anniversary of the Grant Date shown in column 3 above. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter, on the last day of each month.